5.13
5.13 (0.00%)
| Jumlah Dagangan | 1,221,151 |
| Harga / Jualan (P/S) | 0.880 |
| Harga / Buku (P/B) | 0.760 |
| Julat 52 Minggu |
| Margin Keuntungan | -15.96% |
| Margin Operasi (TTM) | -9.49% |
| EPS Cair (TTM) | -0.700 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 10.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2,020.06% |
| Nisbah Semasa (MRQ) | 1.79 |
| Aliran Tunai Operasi (OCF TTM) | -15.64 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 5.58 M |
| Pulangan Atas Aset (ROA TTM) | -17.66% |
| Pulangan Atas Ekuiti (ROE TTM) | -277.62% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Care Facilities (US) | Bercampur | Bercampur |
| Medical Care Facilities (Global) | Menaik | Menaik | |
| Stok | The Oncology Institute, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | NA |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.0 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -2.5 |
| AI Insight | NA |
| Purata | -0.50 |
|
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services. |
|
| Sektor | Healthcare |
| Industri | Medical Care Facilities |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 9.22% |
| % Dimiliki oleh Institusi | 34.63% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
AI Analisis Teknikal
Buka tab Teknikal untuk menjana analisis terkini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |